BioTime

No. Date Reports
8 November 5, 1998 BioTime officers retract statements regarding FDA approval.

7 November 5, 1998 BioTime loses its prime sponsor.

6 October 26, 1998 BioTime posters fail to generate interest or support product claims.

5 October 26, 1998 BioTime Hextend fails to meet priority review standards.

4 May 17, 1998 BioTime analyst issues false report.

3 April 29, 1998 BioTime possesses no valuable product or technology.

2 April 29, 1998 STRONG SELL RECOMMENDATION

1 January 22, 1998 BioTime Strong Sell Recommendation Published in Forbes.